Long-term response to cabergoline and multi-modal treatment in men with macroprolactinoma: Does size really matter?

Yaron RudmanHadar Duskin-BitanYossi ManisterskiBarak PertzovAmit AkirovHiba Masri-IraqiIlan Shimon

Published in: Clinical endocrinology (2021)

Macroprolactinomas in men were controlled with cabergoline in 84% of cases, independent of tumour size. Pituitary surgery and adjuvant radiotherapy further improved long-term response to 91%.

Keyphrases

early stage
minimally invasive
middle aged
coronary artery bypass
radiation therapy
radiation induced
atrial fibrillation
surgical site infection